✦ LIBER ✦

O.127 Phase 2b interim (week 12) results of albumin interferon alpha-2b combined with ribavirin in IFN-naïve, genotype 1 chronic hepatitis C infection

✍ Scribed by Y. Benhamou; S. Zeuzem; D. Shouval; V. Bain; S. Pianko; R. Flisiak; M. Grigorescu; V. Rehak; E. Yoshida; K. Kaita; C. Hezode; A.U. Neumann; M. Subramanian; J. McHutchison

Book ID: 117770162
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 276 KB
Volume: 36
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(06)80121-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

733 Interim (week 12) phase 2b virologic

733 Interim (week 12) phase 2b virological efficacy and safety results of albumin interferon Alpha-2b combined with ribavirin in genotype 1 chronic hepatitis C infection

✍ S. Zeuzem; Y. Benhamou; D. Shouval; V. Bain; S. Pianko; R. Flisiak; M. Grigoresc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 114 KB

[779] ANTIVIRAL RESPONSE AT WEEK 12 FOLL

[779] ANTIVIRAL RESPONSE AT WEEK 12 FOLLOWING COMPLETION OF TREATMENT WITH ALBINTERFERON a-2b PLUS RIBAVIRIN IN GENOTYPE 1, IFN-NAIVE, CHRONIC HEPATITIS C PATIENTS

✍ S. Zeuzem; Y. Benhamou; V. Bain; D. Shouval; S. Pianko; R. Flisiak; M. Grigoresc 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Daily dose of interferon alpha-2b and ri

Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study

✍ GianPiero Benetti; Mauro Borzio; Giuliano Ramella; Giorgio Bellati; Silvia Fargi 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 98 KB

272 EARLY VIRAL RESPONSE OF CONTROLLED-R

272 EARLY VIRAL RESPONSE OF CONTROLLED-RELEASE INTERFERON ALPHA2B AND RIBAVIRIN VS. PEGYLATED-INTERFERON ALPHA2B AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE1 HEPATITIS C: 12 WEEK RESULTS (SELECT-2 TRIAL)

✍ E. Lawitz; Z. Younossi; P. Mehra; A. Rigney; Z. Krastev; K. Tchernev; D. Takov; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

O.062 The safety and efficacy of Viramid

O.062 The safety and efficacy of Viramidine® plus pegylated interferon alpha-2b versus ribavirin plus pegylated interferon alpha-2b in therapy-naïve patients infected with HCV: Phase 3 results

✍ B. Murphy 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 132 KB

S1936 Health-Related Quality of Life (HR

✍ Pianko, Stephen; Yoshida, Eric M.; Zeuzem, Stefan; Benhamou, Yves; Bain, Vincent 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB